Nir Shapir,Reem Miari,Baruch S. Stern,Shany Blum,Avi Rimler
申请号：
US14520831
公开号：
US20150118187A1
申请日:
2014.10.22
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention is directed to long-lasting therapeutic formulations and their methods of use wherein the formulation comprises a genetically modified micro-organ that comprises a nucleic acid sequence operably linked to one or more regulatory sequences. The present invention is further directed to methods providing sustained expression of therapeutic polypeptides and prolonged therapeutic effects, such as erythropoietin and interferon.
